Location: Home
  • search
  • go
  • Relate News
  • 10/17/2025Dianthus Secures Exclusive Global Rights to DNTH212 from China's Leads...
  • 10/17/2025Novo vs. KBP: Fraud or Due Diligence Slipup? (FierceBiotech)
  • 10/13/2025CDE Issues Guidance to Address Common Challenges in Pediatric Drug Dev...
  • 10/13/2025Two Decades of Pediatric Drug Trials in China Reveal Progress and Pers...
  • 9/29/2025China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
  • 9/19/2025China's Sharp API Price Cuts Jeopardize India's Self-Reliance Push
  • 9/19/2025China Produces Dozens of Drugs Below Market Price – U.S. Faces Strate...
  • 9/19/2025Obesity in China (The Lancet)
  • 9/15/2025Hengrui Files PCT Patent for Novel Amylin Analog with Dual Receptor Ac...
  • 9/13/2025CDE Releases First Technical Guidelines for GLP-1 Drugs
  • 9/2/2025Novatim and Radiance Forge Global Licensing Deal for Novel Cancer Ther...
  • 8/21/2025Novo Nordisk Meets NHC Minister to Strengthen Collaboration
  • 8/11/2025Novo Nordisk Reports Solid Growth in China Amid Global Expansion in H1...
  • 8/6/2025Fosun's Exit from Gland Pharma Stalls as Share Price Surge Complicates...
  • 8/1/2025India Moves to Set Minimum Import Prices to Protect Pharma Sector from...
  • 7/21/2025Novo Nordisk, Fangzhou Partner on AI-Powered Diabetes, Obesity Care
  • 7/18/2025China Greenlights New Semaglutide Indication to Combat Kidney and Card...
  • 7/15/2025Hengrui Prepares Chinese NDA for Kailera Drug After Phase 3 Obesity Wi...
  • 7/9/2025China Struggles to Maintain Grip on India's Bulk Drug Market Amid Risi...
  • 7/8/2025Novo Nordisk Commits CNY 800M to Expand Quality Lab at Tianjin Manufac...
  • 7/3/2025Eli Lilly's Tirzepatide Approved in China for Treatment of Obstructive...
  • 7/1/2025Biological E and China's Recbio Partner to Bring HPV9 Vaccine to India...
  • 6/24/2025BrightGene Reports Strong Phase 2 Results for Dual Agonist BGM0504 and...
  • 6/19/2025China Becomes Testing Ground for Weight-Loss Drugs Despite Lower Obesi...
  • 6/16/2025Hengrui Presents Positive Phase 2 Obesity Data at ADA 2025
  • 6/5/2025Mainland Chinese Market for Weight Loss and Diabetes Drugs to Soon Be ...
  • 6/4/2025China's Child Health Improves: NHC Official
  • 5/31/2025China's Breakthru Weight-Loss Drug Makes Landmark Debut in NEJM
  • 5/29/2025CDE Issues Guideline on Safety Assessment and Reporting in Pediatric D...
  • 5/29/2025CDE Launches “Starlight Plan” to Encourage Pediatric Antitumor Drug ...
  • Page:1/43 Total number of articles:1281: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group